Patent · US Active

Bupropion hydrobromide and therapeutic applications

US7645802B2 · kind B2 · utility

4Cited by
6References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2007
Grant dateJan 12, 2010
Priority date—
Expiry dateOct 31, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2013
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.